Research · head to head
Form Bio vs Remesh
Form Bio
Research
Computational platform for cell and gene therapy design and manufacturability
- From
- On request
- Rated
- -
Remesh
Research
Live AI-moderated conversations with hundreds of participants at once, analysed in real time
- From
- On request
- Rated
- -
The short version
- Each has a real cost: Form Bio the company has pivoted twice since spinning out of Colossal Biosciences in 2022, from general computational life sciences to cell and gene therapy and then to AAV manufacturability, so any evaluation more than a year old describes a product that is no longer the commercial focus.; Remesh pricing is not published and third-party estimates put annual contracts in the tens of thousands of dollars, which puts it out of reach for teams that only run occasional qualitative studies and cannot commit to an annual platform fee.
- They diverge on capability: Form Bio covers FormManufacturing, Remesh covers Live moderated sessions.
- Prices and features above were last checked on 31 August 2026.
Where they differ
Only the attributes on which Form Bio and Remesh actually diverge.
Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).
What each one covers
Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.
Only in Form Bio
- FormManufacturing
- Payload design optimisation
- Genome integrity analysis
- Manufacturability prediction
- In silico workflows
- Scale-up monitoring
- Cell and gene therapy focus
- Collaboration
Only in Remesh
- Live moderated sessions
- Collective dialogue
- Flex asynchronous studies
- Video research
- Remy AI assistant
- On-Demand Recruit
- Real-time theme analysis
- Practice sessions
What people use each for
The jobs each tool is most often brought in to do.
Form Bio
- A gene therapy developer discovering manufacturability problems with an AAV construct late in process development and wanting to move that analysis earliernot Remesh
- A biotech comparing several candidate payload designs in silico before committing to expensive production runsnot Remesh
- A CDMO characterising what a client construct actually produces against what was specifiednot Remesh
- A programme team needing genome integrity evidence to support regulatory conversations about product consistencynot Remesh
Remesh
- A brand team that needs to test three positioning statements with 400 target customers and know by the end of the day which one lands and with whomnot Form Bio
- An HR function running an employee listening session across several thousand staff where anonymity and volume both matternot Form Bio
- A public affairs team needing rapid citizen consultation on a policy option with evidence of how widely each objection is heldnot Form Bio
- An insights team that has to replace six focus groups with one session because fieldwork time has been cut and the decision cannot waitnot Form Bio
Where each one falls short
Documented limitations, not opinions. Every one is a constraint you would hit in normal use.
Form Bio
- The company has pivoted twice since spinning out of Colossal Biosciences in 2022, from general computational life sciences to cell and gene therapy and then to AAV manufacturability, so any evaluation more than a year old describes a product that is no longer the commercial focus.
- The current offering launched AAV-focused, so developers working in lentiviral, mRNA or cell therapy modalities are outside the scope the platform was built and validated for.
- No pricing is published and engagements are scoped per programme, which makes it impossible to size the commitment before entering a sales process.
- This is a young venture-funded company whose analyses feed regulatory-facing decisions, so continuity of the vendor over a multi-year development programme is a genuine diligence question rather than a formality.
- Predictive manufacturability models need real production data to be trustworthy, and the value depends on how much of that a young vendor has accumulated, which is difficult for a buyer to verify independently.
Remesh
- Pricing is not published and third-party estimates put annual contracts in the tens of thousands of dollars, which puts it out of reach for teams that only run occasional qualitative studies and cannot commit to an annual platform fee.
- The public review picture is inconsistent in a way worth investigating: a small number of positive buyer reviews on G2 sit alongside a poor Trustpilot rating driven mostly by participant complaints, so ask directly how participants are recruited and compensated before running a study on your own customers.
- Funding has slowed sharply, from a 25 million USD round in 2021 to a 4.25 million USD round in late 2022, so procurement teams at large organisations should expect to run a vendor viability review.
- The collective dialogue mechanic rewards views that many participants recognise and vote for, which systematically under-weights genuinely novel minority insight, so it is a poor fit for exploratory discovery work where the outlier is the point.
- The discussion guide builder, especially spreadsheet import, is reported as unreliable, and because sessions are live with recruited participants a tooling failure during setup is expensive rather than merely annoying.
Pricing, plan by plan
Form Bio
On request- FormManufacturing$undefined/year
- Pricing only through a sales process
- Scoped per therapeutic programme rather than per seat
- AAV-focused offering at launch
Remesh
On request- Remesh$undefined/year
- Live moderated sessions
- Flex asynchronous studies
- Video research
Which should you pick?
Choose Form Bio if
- You need formmanufacturing.
- You work on Web, Cloud.
- You also want payload design optimisation.
Choose Remesh if
- You need live moderated sessions.
- You work on Web, API.
- You also want collective dialogue.
Questions people ask
- Is Form Bio or Remesh better?
- Neither clearly leads. Form Bio starts at On request and Remesh at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
- Which is cheaper, Form Bio or Remesh?
- Form Bio starts at On request and Remesh at On request.
- Does Form Bio or Remesh run on more platforms?
- Form Bio runs on Web, Cloud. Remesh runs on Web, API.
- What is Form Bio best used for?
- Form Bio is most often used for a gene therapy developer discovering manufacturability problems with an aav construct late in process development and wanting to move that analysis earlier, a biotech comparing several candidate payload designs in silico before committing to expensive production runs, a cdmo characterising what a client construct actually produces against what was specified, a programme team needing genome integrity evidence to support regulatory conversations about product consistency. Of those, a gene therapy developer discovering manufacturability problems with an aav construct late in process development and wanting to move that analysis earlier and a biotech comparing several candidate payload designs in silico before committing to expensive production runs are not what Remesh is typically brought in for.
- What can Form Bio do that Remesh cannot?
- Form Bio covers FormManufacturing, Payload design optimisation, Genome integrity analysis, Manufacturability prediction. Remesh covers Live moderated sessions, Collective dialogue, Flex asynchronous studies, Video research.
Answered from the vendors’ own pages
Form Bio: What does Form Bio sell now?
FormManufacturing, launched in 2026, an AAV-focused platform for predicting, optimising and monitoring manufacturability of genetic medicines from construct design through scale-up.
Remesh: How many people can join one session?
Sessions are designed for several hundred participants at once, which is the core reason to choose it over a conventional focus group.
Form Bio: Is it still a general bioinformatics platform?
No. It has narrowed from broad computational life sciences tooling to cell and gene therapy, and within that to AAV.
Remesh: Does it publish pricing?
No. Contracts are quoted annually, typically scoped by session volume, and third-party estimates place them in the tens of thousands of dollars per year.
Form Bio: Where did the company come from?
It spun out of Colossal Biosciences in 2022.
Remesh: Can it replace a survey?
Not entirely. It produces open-ended language with agreement percentages, which is stronger than a survey for understanding reasoning but weaker for precise population estimates.
Form Bio: Is pricing published?
No. Engagements are scoped per programme through a sales process.
Remesh: Does Remesh recruit participants for me?
Yes, through On-Demand Recruit, typically delivering a panel within about 24 hours, or you can bring your own list.
Related pages
Other head to heads
- Form Bio vs Benchling
- Form Bio vs DNAnexus
- Form Bio vs Dotmatics
- Form Bio vs Seven Bridges
- Form Bio vs Terra
- Form Bio vs OpenEye, Cadence Molecular Sciences
- Form Bio vs Schrodinger
- Form Bio vs Sapio Sciences
- Form Bio vs Mouseflow
- Form Bio vs Chemaxon
- Form Bio vs Labguru
- Form Bio vs Obsidian
- Form Bio vs Paperpile
- Form Bio vs Reduct
- Form Bio vs Scispot
- Form Bio vs Dovetail
- Form Bio vs Suzy
- Form Bio vs Aurelius
- Form Bio vs SurveyMonkey
- Form Bio vs Zappi
- Form Bio vs GWI
- Form Bio vs TetraScience
- Form Bio vs STARLIMS
- Form Bio vs NVivo
- Form Bio vs Condens
- Form Bio vs Greenphire
- Form Bio vs Marvin
- Form Bio vs Castor EDC
- Remesh vs Benchling
- Remesh vs DNAnexus
- Remesh vs Dotmatics
- Remesh vs Seven Bridges
- Remesh vs Terra
- Remesh vs OpenEye, Cadence Molecular Sciences
- Remesh vs Schrodinger
- Remesh vs Sapio Sciences
- Remesh vs Mouseflow
- Remesh vs Chemaxon
- Remesh vs Labguru
- Remesh vs Obsidian
- Remesh vs Paperpile
- Remesh vs Reduct
- Remesh vs Scispot
- Remesh vs Dovetail
- Remesh vs Suzy
- Remesh vs Aurelius
- Remesh vs SurveyMonkey
- Remesh vs Zappi
- Remesh vs GWI
- Remesh vs TetraScience
- Remesh vs STARLIMS
- Remesh vs NVivo
- Remesh vs Condens
- Remesh vs Greenphire
- Remesh vs Marvin
- Remesh vs Castor EDC